Biotherapeutics Analytical Summit 2020

COVID-19 update May 2020: due to the COVID-19 pandemic, the Biotherapeutics Analytical Summit has been rescheduled to September 28 – October 2, 2020 at the same venue, the Westin Alexandria Hotel.

March 2020: Cambridge Healthtech Institute (MA, USA) is closely monitoring the continuing developments on COVID-19. Currently, there is no plan to cancel or postpone the Biotherapeutics Analytical Summit 2020.

The Biotherapeutics Analytical Summit 2020 will be the 11^th Annual summit bringing together analytical scientists from biotherapeutics discovery, analytical development, pharmaceutical sciences, process and technical development to discuss their experience and share best practices on developing and characterizing new molecules.

Keynote and featured speakers have now been announced! Speakers include Alain Beck (Senior Director, Biologics CMC & Developability, Center for Immunology, Pierre Fabre, Saint-Julien-en-Genevois, France), Satish Singh (Head of Sterile Product Technology, Moderna Therapeutics (MA, USA), Nadine Ritter (President and Analytical Advisor, Global Biotech Experts, DC, USA), John Marino (Group Leader, Biomolecular Structure and Function Group, NIST, MD, USA) and Emily Shacter (Consultant, ThinkFDA, DC, USA).

---

You might also be interested in…

Biotherapeutic characterization and quantification: an interview with Pegah Jalili

Conference and event highlights: April to June

End of the road? The future of chromatography

---

Over the 5 day conference, the Biotherapeutics Analytical Summit 2020 will focus on: the early analytical development of therapeutics; impurities and degradants, characterizing novel modalities, advances in characterization, comparability and stability and will also host a number of training seminars and short courses.

To find out more, including a comprehensive program, list of short courses and registration information, visit the Biotherapeutics Analytical Summit 2020 website.